Reporting of granting of Tryg shares Mikael Kärrsten (CTO)

Group CTO Mikael Kärrsten has been granted 2,318 Tryg shares for a total amount of DKK 368,098. Granting of the shares are related to the acquisition of TryggHansa in 2021.

Attachment

19_2024.30.09

Reporting of granting of Tryg shares Mikael Kärrsten (CTO)

PDD Holdings: Temu Parent Surges On China’s Stimulus – Is Ray Dalio’s Pick Back In Action?

NZD/USD Hits Seven-Week Low Amid Ongoing Sell-Off And RBNZ Rate Cuts

Clearside Biomedical’s Investigational Drug For Vision Loss Hits Primary Goals In Mid-Stage Study

Turkey’s BRICS Bid Should Trouble Europe

Why NIO Stock Is Down 10% This Week

Topics

PDD Holdings: Temu Parent Surges On China’s Stimulus – Is Ray Dalio’s Pick Back In Action?

NZD/USD Hits Seven-Week Low Amid Ongoing Sell-Off And RBNZ Rate Cuts

Clearside Biomedical’s Investigational Drug For Vision Loss Hits Primary Goals In Mid-Stage Study

Turkey’s BRICS Bid Should Trouble Europe

Why NIO Stock Is Down 10% This Week

Tesla Unusual Options Activity

Booking Holdings Unusual Options Activity For October 09

Information relating to the total number of voting rights and share capital – September 30, 2024

Related Articles

PDD Holdings: Temu Parent Surges On China’s Stimulus – Is Ray Dalio’s Pick Back In Action?

NZD/USD Hits Seven-Week Low Amid Ongoing Sell-Off And RBNZ Rate Cuts

Clearside Biomedical’s Investigational Drug For Vision Loss Hits Primary Goals In Mid-Stage Study

Turkey’s BRICS Bid Should Trouble Europe

Why NIO Stock Is Down 10% This Week

Company

Headlines

PDD Holdings: Temu Parent Surges On China’s Stimulus – Is Ray Dalio’s Pick Back In Action?

NZD/USD Hits Seven-Week Low Amid Ongoing Sell-Off And RBNZ Rate Cuts

Clearside Biomedical’s Investigational Drug For Vision Loss Hits Primary Goals In Mid-Stage Study

Turkey’s BRICS Bid Should Trouble Europe

Newsletter